OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
18 hedge funds and large institutions have $44.6M invested in Ocera Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
18
Holders Change
+8
Holders Change %
+80%
% of All Funds
0.52%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
10
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VM
1
VHCP Management
New York
|
$9.14M |
| 2 |
QF
2
QVT Financial
New York
|
$8.65M |
| 3 |
GPP
3
Great Point Partners
Greenwich,
Connecticut
|
$6.86M |
| 4 |
RCM
4
RA Capital Management
Boston,
Massachusetts
|
$8.6M |
| 5 |
DM
5
Deerfield Management
New York
|
$2.74M |
Top Sellers
| 1 |
1
Dimensional Fund Advisors
Austin,
Texas
|
$0 |
| 2 |
U
2
UBS
Zurich,
Switzerland
|
$0 |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$8K |
